Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acquisition, advisor, agreed, aimed, al, allegedly, alternative, attain, attention, avoid, background, breadth, build, burden, capability, case, cease, certificate, chain, challenging, choose, Committee, complaint, consummate, consummated, consummating, consummation, contemplated, core, correctly, costly, court, Demurjian, depth, description, devoting, DGCL, diligence, disseminate, District, divert, effectuate, enjoining, entry, equal, exacerbate, expand, failure, firm, foregoing, forward, frequently, harm, Hoffman, impose, incomplete, inflation, injectable, injunction, interfere, Irwin, joint, July, lump, macroeconomic, matter, merge, merger, Michael, misleading, momentum, motivate, opinion, outcome, path, pause, pendency, Piper, plaintiff, postpone, proxy, purported, pursuit, Ratio, recession, recommendation, relief, represent, requested, requesting, rescissory, retention, reverse, Sandler, Science, spending, stockholder, successfully, Tack, unanticipated, undertook, unexpected, view, vote, Voting, waiver, war, wholly
Removed:
accounted, applying, appointed, begin, beginning, begun, beneficial, cancellation, closeout, CMBTsTM, collectability, collectively, colorectal, commenced, complexity, conversion, convertible, Cunningham, delayed, ease, efficiency, eligible, examining, facet, filer, franchise, fundamental, greater, group, Hedging, improving, initiative, investigational, marketability, mice, month, mouse, November, occurring, overlooked, partially, permitted, progression, pronouncement, recognition, remeasured, removal, renewed, resolve, Richie, scale, settled, settlement, simplification, Simplifying, stop, Subtopic, supportable, unacceptable, unlock, untapped, vi, xenograft
Financial report summary
?Risks
- The announcement and pendency of the Merger with Syros may result in disruptions to our business.
- Following the Merger with Syros, the combined company may be unable to integrate successfully and realize the anticipated benefits of the Merger.
- If the Merger with Syros is not consummated and we are unable to identify and implement an alternative strategic option, we may choose to close down our trials and cease operations.
- We may be unable to regain and maintain compliance with The Nasdaq Capital Market continued listing requirements, which could cause our common stock to be delisted from The Nasdaq Capital Market. This could result in the lack of a market for our common stock, cause a decrease in the value of an investment in Tyme, and adversely affect our business, financial condition, and results of operations.
Management Discussion
- Net loss for the year ended March 31, 2022 was $23,626,000 or $0.14 per share compared to $28,979,000 or $0.22 per share for the year ended March 31, 2021. The decrease in the net loss compared to the prior year was due to the non-cash favorable variance of $5,722,000 in the change in fair value of the warrant liability and decreased operating costs, offset by $2,229,000 prior years gain on the warrant exchange. The decrease in operating costs for the current year of $1,703,000 related to decreased research and development costs of $3,264,000 and decreased general and administrative costs of $554,000, partially offset by $2,115,000 increased severance expenses, explained below under “Operating Expenses.”